Searched for
PRAKASH MANCHANDA
Add Dr Lal Pathlabs, target price Rs 2,910: HDFC SecuritiesHDFC Securities has an 'add' call on Dr Lal Pathlabs with a target price of Rs 2910. The company reported a total income of Rs 621.80 crore...- Jindal & Melligeri among industry leaders named on Invest Karnataka ForumThe State Government of Karnataka has formed the Board of Invest Karnataka Forum (IKF) and the Strategic Investments Committee (SIC) to att...
- Reduce Dr. Lal Pathlabs, target price Rs 1875: Yes SecuritiesReduce Dr. Lal Pathlabs at a price target of Rs 1875.
- Buy Dr. Lal Pathlabs, target price Rs 2620: JM FinancialDr. Lal Pathlabs, incorporated in the year 1995, is a Mid Cap company (having a market cap of Rs 15012.92 Crore) operating in Hospitals & A...
- Buy Dr. Lal Pathlabs, target price Rs 2820: BNP Paribas SecuritiesPromoters held 55.05 per cent stake in the company as of 30-Sep-2022, while FIIs owned 22.37 per cent, DIIs 6.27 per cent.
- Dr Lal pulls up its socks as competition mountsGurgaon-headquartered Dr Lal PathLabs and other diagnostic chains are feeling the heat due to the big drop in demand for Covid-19 testing, ...
- Dr Lal PathLabs pulls up its socks as competition mountsGurgaon-headquartered Dr Lal PathLabs and other diagnostic chains are feeling the heat due to the big drop in demand for Covid-19 testing, ...
- Trending stocks: Dr. Lal Pathlabs shares climb over 2%A total of 1,892 shares changed hands on the counter till 10:58AM (IST).
- Outlook for diagnostics industry favourable for growth: Dr Lal PathLabsThe company said it served 1.94 crore patients and processed 4.77 crore samples
- Gautam Gambhir urges BCCI to dissolve DDCA after fracas during its AGMA source said the AGM was "disrupted by supporters of general secretary Vinod Tihara after resolution 3, 4 and removal of its Ombudsman Jus...
- Buy Dr. Lal Pathlabs, target Rs 1,249: Dharmesh ShahBuy Dr. Lal Pathlabs Ltd. at a price target of Rs 1249.0 and a stoploss at Rs 1136 from entry point.
- Buy Dr Lal Pathlabs, target Rs 1,235: Dharmesh ShahBuy Dr. Lal Pathlabs Ltd. at a price target of Rs 1235.0 and a stoploss at Rs 1148 from entry point.
- Buy Dr. Lal Pathlabs, target Rs 900: Edelweiss Financial ServicesBuy Dr. Lal Pathlabs at a price target of Rs 900. Time period given by analyst is a year when Dr. Lal Pathlabs price can reach defined targ...
- 4 Delhi students among winners in Mars Art Contest 2017New Delhi, July 8 (IANS) Four students from Delhi secured second and third positions in the US-based Mars Society's international "Student ...
- Normally Q2 is the highest quarter both in terms of revenue as well as volume: Om Prakash Manchanda, Whole-time Director & CEO, Dr Lal Pathlabs LtdIn an interview with ET Now, Om Prakash Manchanda, Whole-time Director & CEO, Dr Lal Pathlabs Ltd, gives his views on the company's Q2 resu...
- The A-Team: How female co-founders can be a tremendous asset to any startupFemale co-founders could serve as a tremendous asset for any startup because it brings a diversity of views, experiences and thought proces...
- Dr Lal Pathlabs looking to expand; 20% CAGR likely to sustain: Om Prakash Manchanda, CEO"The market is growing at 16% to 17%. Our own growth is likely to be sustainable as we expand to newer markets and grow further — both orga...
- E-retailers blend it right for tea connoisseursIndia’s large tea market—total branded tea market in India is estimated to be worth about Rs 10,000 crore and growing at over 15% annually.
- Bishan Singh Bedi panel crushes to defeat in DDCA pollsSneh Prakash Bansal and his panel today swept the DDCA polls with a landslide victory over Bedi's faction by procuring more than 70 pc of t...
- Entrepreneurs building dream bizTwo of the entrepreneurs who sold their companies this year are already working on starting up new biz venture.
Load More
